形式
solution
包装
pkg of 1 × 5 mL (with stopper and crimp cap (300105S-1EA))
制造商/商品名称
Avanti Research™ - A Croda Brand 300105S
运输
wet ice
储存温度
2-8°C
正在寻找类似产品? 访问 产品对比指南
一般描述
Concentration: 2 mg/ml doxorubicin HCl at pH 6.5-6.8, in 10 mM histidine buffer, with 10% w/v sucrose.Particle size and shape: Dox-NP™ mean particle size is 80 to 90 nm, with very small poly-dispersity valuePurity: >=90% of the drug is encapsulated in the long-circulating, pegylated, liposomes.Formulation: The long-circulating, pegylated, liposomal carrier is composed of N-(carbonyl-ethoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine sodium salt (MPEG-DSPE), 3.19 mg/ml; fully hydrogenated soy phosphatidylcholine (HSPC), 9.58 mg/ml; cholesterol, 3.19 mg/ml, ammonium sulfate, approximately 2 mg/ml; histidine as a buffer; hydrochloric acid or sodium hydroxide for pH control; and sucrose to maintain isotonicity. Dox-NP™ is provided as a sterile, translucent, red liposomal dispersion in single-use, 2 ml or 5 ml vials.Buffer: 10 mM histidine buffer, pH 6.5-6.8, with 10% w/v sucrose.
应用
Intravenous (i.v.) injection in flank or orthotopic animal models of cancer.
包装
10 mL Clear Glass Vial with Stopper and Crimp Cap (300105S-1EA)
储存及稳定性
Store undiluted at 2°-8° C. Do Not Freeze.
法律信息
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Dox-NP is a trademark of Avanti Polar Lipids, LLC
警示用语：
Danger
危险声明
危险分类
Carc. 1B - Muta. 1B
储存分类代码
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门